Robert Wood Johnson Medical School
Strategic Priorities: Research
Introduction (continued)
As part of the RBHS capital master plan, the new research facilities
in the New Brunswick community will strengthen collaborations
between basic and clinical scientists and enrich the research
mission. Many of the complementary programs are addressed
through the pediatric and adult clinical research centers (CRCs) that
will continue to play a prominent role in translational research and
the RBHS effort to receive a National Institutes of Health (NIH)
Clinical and Translational Science Award (CTSA). The New
Brunswick based CRCs will increase clinical trials that translate the
bench-to-bedside discoveries leading to drug development and
other therapies to improve the health of New Jersey residents and
overall public health across the globe. Additionally, the bench-to-
bedside pathway will provide opportunity for greater public-private
partnerships with the bio-pharma industry as set forth